Electrolyte tablets recalled after posing ‘unacceptable’ risk to pregnant women

Electrolyte tablets recalled after posing ‘unacceptable’ risk to pregnant women

22nd May 2021 Off By adpublisher

The Therapeutic Goods Administration (TGA) has recalled 10 batches of Hydralyte’s Strawberry Kiwi Effervescent electrolyte tablets.

The batches were recalled over fears pregnant women taking the tablets may miscarry due to the presence of Carthamus tinctorius as an inactive ingredient in the hydration product.

“The level of exposure of Carthamus tinctorius (safflower) in this product poses an unacceptable risk if used in pregnancy”, the TGA said.

Carthamus tinctorius, a commercially cultivated plant, can cause menstruation and contractions that may end in miscarriage.

“Further, the product does not contain the mandatory label warning ‘Do not use if pregnant or likely to become pregnant’ due to the inclusion of Carthamus tinctorius as an inactive ingredient,” the TGA said.

The statement was released after an investigation by the regulatory authority.

The issue is limited to the Strawberry Kiwi Effervescent tablets and does not affect other Hydralyte flavours or products.

The recall affects the following batches: L9136/1, L9198/7, L9268/5, L9309/1, L0108/11, L0205/4, L0031/7, L0031/8, L0066/4 and L0311/5.

Women are advised to stop using the tablets if they are already pregnant or likely to fall pregnant.

Consumers are entitled to a full refund.